Share

Updates matching "National"

March 4, 2024
National

Today, the U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Braidwood Management v. Becerra, a case that threatens access to evidence-based preventive services without cost-sharing as required under the Affordable Care Act (ACA). The services at-risk include those recommended by scientific experts at the U.S. Preventive Services Task Force (USPSTF), the Advisory Committee on Immunization Practices (ACIP) and the Health Resources and Services Administration (HRSA).

February 26, 2024
National

ACS CAN volunteers recently traveled to Washington, D.C., from across the nation to join more than 200 other cancer patients, survivors and family members from 32 states and the District of Columbia in the nation’s capital for the 14 th Annual Alliance for Childhood Cancer Action Days, a two-day event

February 22, 2024
National

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.

February 14, 2024
National

Dr. Christina Annunziata , the Senior Vice President of Extramural Discovery Science at the American Cancer Society, testified today before the House Committee on Energy and Commerce’s Subcommittee on Health in support of the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act and the Women and Lung Research and Preventive Services Act.

February 14, 2024
National

Protecting free preventive cancer screenings and reducing the burden of medical debt are the top issues of concern for cancer patients and survivors today, according to a new survey by the American Cancer Society Cancer Action Network (ACS CAN) that asked participants to select their leading policy priorities for the year.

February 6, 2024
National

Today, the American Cancer Society Cancer Action Network (ACS CAN) issued a letter to the National Institutes of Standards and Technology (NIST) commenting on the utilization of march-in rights (MIR) to lower prescription drug costs following the release of new guidance by the administration on its application.

February 2, 2024
National

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 20 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow clinical trial sponsors to financially support

February 2, 2024
National

On the two-year anniversary of the reignited Cancer Moonshot, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the White House and Congress to reinforce their commitment to end cancer as we know it by taking key steps to prioritize cancer prevention and research.

January 31, 2024
National

Our 25 organizations, representing patients with serious health conditions and providers who care for them, urge the Supreme Court to reverse the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al. because it threatens patients’ and providers’ ability to rely on Food and Drug Administration (FDA) decisions about drug safety.